This inventor holds 3 USPTO granted patents and 8 published patent applications. Top assignee: Scribe Therapeutics Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Cole Urnes: Innovator in Immunotherapy
Introduction
Cole Urnes is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of immunotherapy, holding a total of 3 patents. His work focuses on developing advanced systems for gene modification and therapeutic applications.
Latest Patents
Urnes's latest patents include innovative compositions and methods for use in immunotherapy. One of his notable inventions is the CasX:gNA system, which comprises CasX proteins and guide nucleic acids (gNAs). This system is designed for modifying cell genes that are crucial for antigen processing, presentation, recognition, and response. Additionally, it includes methods for producing and utilizing populations of cells with these modified genes. In some cases, the modified cells express chimeric antigen receptors (CAR) or engineered T cell receptors (TCR), making them valuable for immunotherapy applications.
Another significant patent focuses on the targeting of the SOD1 gene. This invention also utilizes the CasX:gNA system, which is beneficial for modifying cells with mutations in the SOD1 protein or its regulatory elements. The methods developed by Urnes aim to treat subjects with SOD1-related diseases, showcasing his commitment to advancing medical science.
Career Highlights
Cole Urnes is currently associated with Scribe Therapeutics Inc., where he continues to push the boundaries of genetic engineering and immunotherapy. His work has garnered attention for its potential to revolutionize treatment options for various diseases.
Collaborations
Urnes collaborates with talented individuals such as Kian Taylor and Katherine Baney, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Cole Urnes stands out as a key figure in the field of immunotherapy, with a focus on gene modification technologies. His patents reflect a deep understanding of the complexities of antigen processing and therapeutic applications. Through his work, he is making significant strides toward improving treatment options for patients with genetic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile